Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

You are here

Home » Neonatal Toxoplasma gondii IgM FEIA
Connect with this vendor - Learn about this product
Add to Favourite List
Request Info
View Catalogs

Neonatal Toxoplasma gondii IgM FEIA

Trivitron Healthcare
Category: 
Laboratory

Labsystems Diagnostics' Neonatal Toxoplasma gondii IgM FEIA is a fluorometric enzyme immunoassay intended for the determination of IgM-class antibodies to Toxoplasma gondii in blood samples dried on filter paper. The test is intended as a primary method for screening newborns for congenital toxoplasmosis (CT).

OVERVIEW

In a 5 year study in Brazil over 285 000 neonates were screened with Labsystems Diagnostics' Neonatal Toxoplasma gondii IgM FEIA and the prevalence was found to be 1/1867.

Fluorometric enzyme immunoassay for the determination of IgM antibodies to Toxoplasma gondii from dried blood spots. This is the first Neonatal Toxoplasma screening test in the world.

TECHNICAL SPECIFICATIONS

Neonatal Toxoplasma gondii IgM FEIA, 5 strip plates (12x8), 480 wells 61 99 802

BENEFITS

First Neonatal Toxoplasma screening test in the world

Quantitative results

Clinically proven performance

High sensitive µ-capture test

View this product at labsystemsdx.com
We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy and Cookie Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
I Agree